Australian company surges on coronavirus contract wins

According to The Australian Financial Review, shares in ASX minnow Micro-X Ltd surged 29 per cent after the Adelaide-based manufacturer said it secured two orders from south east Asian governments seeking to use its X-ray technology to help diagnose the coronavirus.
The company’s first product, the Carestream DRX Revolution Nano, is an ultra-lightweight digital medical X-ray system for the expanding mobile X-ray market in hospitals. Micro-X said production has moved to full capacity to fulfil all these orders within four weeks.
CEO Peter Rowland said chest X-rays are a key tool in monitoring the progression of the pneumonia-like symptoms of severe coronavirus infection.
While the normal early-stage diagnosis of coronavirus is by a blood test, like with pneumonia, a chest X-ray is used to detect fluid in the lungs, particularly with patients presenting with severe acute respiratory distress.

https://www.afr.com/companies/healthcare-and-fitness/micro-x-surges-on-coronavirus-contract-wins-20200213-p540ln

If you want to read this article in Japanese, please see the following link:
https://www.j-abc.com/jp-blog/8231665.html 
​